Browsing Tag
Osaka
4 posts
GSK locks in ViiV Healthcare majority as Shionogi doubles down and Pfizer exits with $1.8bn
GSK retains 78.3% of ViiV Healthcare as Shionogi doubles its stake to 21.7% for $2.125 bn and Pfizer exits. Read the full strategic analysis.
Bain Capital’s $3.3bn acquisition of Mitsubishi Tanabe Pharma aims to reshape Japan’s pharmaceutical landscape
Bain Capital, a prominent global private investment firm, has announced a definitive agreement to acquire Mitsubishi Tanabe Pharma…
Gunze Limited announces major expansion with third medical plant in Kyoto
Osaka’s renowned Gunze Limited is setting the stage for a significant expansion in Ayabe, Kyoto, with an investment…
Sawai Pharmaceutical to acquire generic pharma business of Upsher-Smith
Japanese pharma company Sawai Pharmaceutical will acquire American generic drug maker Upsher‐Smith Laboratories’s generic pharma business for nearly…